Related Experiment Video
Updated: May 25, 2026

11:36
In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function
Yu-Chi Juang1, Marie-Claude Landry, Mario Sanches
1Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON M5G 1X5, Canada.
Molecular Cell
|February 14, 2012
Summary
The deubiquitylase OTUB1 inhibits the DNA damage response by blocking ubiquitin transfer. OTUB1 utilizes free ubiquitin binding to suppress E2 enzyme activity, impacting DNA repair.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Biology
Background:
- Ubiquitylation is a crucial post-translational modification mediated by E1, E2, and E3 enzymes.
- OTUB1, a deubiquitylase, was previously shown to inhibit the DNA damage response independent of its enzymatic activity.
- OTUB1 inhibits ubiquitin transfer by E2 enzymes like UBC13, UBE2D, and UBE2E.
Purpose of the Study:
- To elucidate the structural mechanism by which OTUB1 binds E2 enzymes and inhibits ubiquitin transfer.
- To understand how OTUB1's interaction with E2s impacts the DNA damage response.
Main Methods:
- X-ray crystallography to determine the structure of OTUB1 bound to E2 enzymes and ubiquitin.
- Biochemical assays to measure ubiquitin transfer activity in the presence of OTUB1 and ubiquitin.
Main Results:
- OTUB1 recognizes ubiquitin-charged E2 enzymes through interactions with both the donor ubiquitin and the E2 enzyme.
- Free ubiquitin binds to OTUB1's distal ubiquitin-binding site, promoting the formation of an inhibited E2 complex.
- The binding configuration mimics Lys48-linked ubiquitin chain cleavage products, with Lys48 of donor ubiquitin positioned near OTUB1's catalytic site.
Conclusions:
- OTUB1 employs a novel mechanism to inhibit ubiquitin conjugation by hijacking Lys48-linked ubiquitin chain recognition.
- This interaction suppresses E2 enzyme activity, thereby inhibiting the DNA damage response.
- The findings provide structural insights into deubiquitylase regulation and its role in DNA repair pathways.
Related Concept Videos
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
Export of Misfolded Proteins out of the ER
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...

